Publications by authors named "David M Peereboom"

66Publications

A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.

Authors:
David M Peereboom Xiaobu Ye Tom Mikkelsen Glenn J Lesser Frank S Lieberman H Ian Robins Manmeet S Ahluwalia Andrew E Sloan Stuart A Grossman

Neurosurgery 2021 Jan;88(2):246-251

The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article and Find Full Text PDF
January 2021

Exploring Predictors of Response to Dacomitinib in -Amplified Recurrent Glioblastoma.

Authors:
Andrew S Chi Daniel P Cahill David A Reardon Patrick Y Wen Tom Mikkelsen David M Peereboom Eric T Wong Elizabeth R Gerstner Jorg Dietrich Scott R Plotkin Andrew D Norden Eudocia Q Lee Lakshmi Nayak Shota Tanaka Hiroaki Wakimoto Nina Lelic Mara V Koerner Lindsay K Klofas Mia S Bertalan Isabel C Arrillaga-Romany Rebecca A Betensky William T Curry Darrel R Borger Leonora Balaj Robert R Kitchen Sudipto K Chakrabortty Michael D Valentino Johan Skog Xandra O Breakefield A John Iafrate Tracy T Batchelor

JCO Precis Oncol 2020 8;4. Epub 2020 Jun 8.

Massachusetts General Hospital and Harvard Medical School, Boston, MA.

View Article and Find Full Text PDF
June 2020

Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.

Authors:
Tyler J Alban Defne Bayik Balint Otvos Anja Rabljenovic Lin Leng Leu Jia-Shiun Gustavo Roversi Adam Lauko Arbaz A Momin Alireza M Mohammadi David M Peereboom Manmeet S Ahluwalia Kazuko Matsuda Kyuson Yun Richard Bucala Michael A Vogelbaum Justin D Lathia

Front Immunol 2020 18;11:1191. Epub 2020 Jun 18.

Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, United States.

View Article and Find Full Text PDF
June 2020

Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery.

Authors:
Stuart A Grossman Carlos G Romo Michelle A Rudek Jeffrey Supko Joy Fisher L Burt Nabors Patrick Y Wen David M Peereboom Benjamin M Ellingson William Elmquist Fred G Barker David Kamson Jann N Sarkaria William Timmer Ranjit S Bindra Xiaobu Ye

Neuro Oncol 2020 10;22(10):1422-1424

Johns Hopkins University, Baltimore, Maryland.

View Article and Find Full Text PDF
October 2020

Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma.

Authors:
Prakash Ambady Rongwei Fu Laszlo Szidonya David M Peereboom Nancy D Doolittle Edward A Neuwelt

J Neurooncol 2020 Mar 5;147(1):171-176. Epub 2020 Feb 5.

Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, L603, Portland, OR, 97239, USA.

View Article and Find Full Text PDF
March 2020

Large B-cell lymphoma of the uvea: Histopathologic variants and clinicopathologic correlation.

Authors:
Juan Valenzuela Gabrielle A Yeaney Eric D Hsi Elizabeth M Azzato David M Peereboom Arun D Singh

Surv Ophthalmol 2020 May - Jun;65(3):361-370. Epub 2019 Oct 30.

Department of Ophthalmic Oncology, Cole Eye Institute of the Cleveland, Cleveland, OH, USA. Electronic address:

View Article and Find Full Text PDF
October 2019

Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells.

Authors:
David M Peereboom Tyler J Alban Matthew M Grabowski Alvaro G Alvarado Balint Otvos Defne Bayik Gustavo Roversi Mary McGraw Pengjing Huang Alireza M Mohammadi Harley I Kornblum Tomas Radivoyevitch Manmeet S Ahluwalia Michael A Vogelbaum Justin D Lathia

JCI Insight 2019 11 14;4(22). Epub 2019 Nov 14.

Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA.

View Article and Find Full Text PDF
November 2019

Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.

Authors:
Martin C Tom Deborah Y J Park Kailin Yang C Marc Leyrer Wei Wei Xuefei Jia Vamsi Varra Jennifer S Yu Samuel T Chao Ehsan H Balagamwala John H Suh Michael A Vogelbaum Gene H Barnett Richard A Prayson Glen H J Stevens David M Peereboom Manmeet S Ahluwalia Erin S Murphy

Int J Radiat Oncol Biol Phys 2019 12 25;105(5):1106-1112. Epub 2019 Aug 25.

Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio.

View Article and Find Full Text PDF
December 2019

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.

Authors:
Patrick Y Wen David A Reardon Terri S Armstrong Surasak Phuphanich Robert D Aiken Joseph C Landolfi William T Curry Jay-Jiguang Zhu Michael Glantz David M Peereboom James M Markert Renato LaRocca Donald M O'Rourke Karen Fink Lyndon Kim Michael Gruber Glenn J Lesser Edward Pan Santosh Kesari Alona Muzikansky Clemencia Pinilla Radleigh G Santos John S Yu

Clin Cancer Res 2019 10 18;25(19):5799-5807. Epub 2019 Jul 18.

Cedars-Sinai Medical Center, Los Angeles, California.

View Article and Find Full Text PDF
October 2019

Phase II study of Dovitinib in recurrent glioblastoma.

Authors:
Mayur Sharma Cathy Schilero David M Peereboom Brian P Hobbs Paul Elson Glen H J Stevens Keith McCrae Andrew B Nixon Manmeet S Ahluwalia

J Neurooncol 2019 Sep 11;144(2):359-368. Epub 2019 Jul 11.

Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, S73, Cleveland, OH, 44195, USA.

View Article and Find Full Text PDF
September 2019

Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era.

Authors:
Martin C Tom Vamsi Varra C Marc Leyrer Deborah Y Park Samuel T Chao Jennifer S Yu John H Suh Chandana A Reddy Ehsan H Balagamwala James R Broughman Kiran A Kotagal Michael A Vogelbaum Gene H Barnett Manmeet S Ahluwalia David M Peereboom Richard A Prayson Glen H J Stevens Erin S Murphy

Int J Radiat Oncol Biol Phys 2019 08 22;104(5):1099-1105. Epub 2019 Apr 22.

Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article and Find Full Text PDF
August 2019

The Impact of Sequencing PD-1/PD-L1 Inhibitors and Stereotactic Radiosurgery for Patients with Brain Metastasis.

Authors:
Rupesh Kotecha Joseph M Kim Jacob A Miller Aditya Juloori Samuel T Chao Erin S Murphy David M Peereboom Alireza M Mohammadi Gene H Barnett Michael A Vogelbaum Lilyana Angelov John H Suh Manmeet S Ahluwalia

Neuro Oncol 2019 Feb 23. Epub 2019 Feb 23.

Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland, OH.

View Article and Find Full Text PDF
February 2019

Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.

Authors:
Shireen Parsai Jacob A Miller Aditya Juloori Samuel T Chao Rupesh Kotecha Alireza M Mohammadi Manmeet S Ahluwalia Erin S Murphy Gene H Barnett Michael A Vogelbaum Lilyana Angelov David M Peereboom John H Suh

J Neurosurg 2019 02;132(2):503-511

Departments of1Radiation Oncology and.

View Article and Find Full Text PDF
February 2019

Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis.

Authors:
Joseph M Kim Jacob A Miller Rupesh Kotecha Samuel T Chao Manmeet S Ahluwalia David M Peereboom Alireza M Mohammadi Gene H Barnett Erin S Murphy Michael A Vogelbaum Lilyana Angelov Jame Abraham Halle Moore G Thomas Budd John H Suh

Neuro Oncol 2019 05;21(5):659-668

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio.

View Article and Find Full Text PDF
May 2019

First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1.

Authors:
Michael A Vogelbaum Cathy Brewer Gene H Barnett Alireza M Mohammadi David M Peereboom Manmeet S Ahluwalia Shenqiang Gao

J Neurosurg 2018 Apr 1:1-10. Epub 2018 Apr 1.

3Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio.

View Article and Find Full Text PDF
April 2018

Risk Factors for Malignant Transformation of Low-Grade Glioma.

Authors:
Erin S Murphy Charles M Leyrer Michael Parsons John H Suh Samuel T Chao Jennifer S Yu Rupesh Kotecha Xuefei Jia David M Peereboom Richard A Prayson Glen H J Stevens Gene H Barnett Michael A Vogelbaum Manmeet S Ahluwalia

Int J Radiat Oncol Biol Phys 2018 03 21;100(4):965-971. Epub 2017 Dec 21.

Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.

View Article and Find Full Text PDF
March 2018

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Authors:
D Ross Camidge Eudocia Q Lee Nancy U Lin Kim Margolin Manmeet S Ahluwalia Martin Bendszus Susan M Chang Janet Dancey Elisabeth G E de Vries Gordon J Harris F Stephen Hodi Andrew B Lassman David R Macdonald David M Peereboom David Schiff Ricardo Soffietti Martin J van den Bent Jeffrey S Wefel Patrick Y Wen

Lancet Oncol 2018 01;19(1):e20-e32

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
January 2018

Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.

Authors:
Mahmoud Abbassy Symeon Missios Gene H Barnett Cathy Brewer David M Peereboom Manmeet Ahluwalia Gennady Neyman Samuel T Chao John H Suh Michael A Vogelbaum

Neurosurgery 2018 09;83(3):385-392

Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, Ohio.

View Article and Find Full Text PDF
September 2018

Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.

Authors:
Erin S Murphy Kevin Rogacki Andrew Godley Peng Qi Chandana A Reddy Manmeet S Ahluwalia David M Peereboom Glen H Stevens Jennifer S Yu Rupesh Kotecha John H Suh Samuel T Chao

Pract Radiat Oncol 2017 Nov - Dec;7(6):e391-e399. Epub 2017 Apr 12.

Department of Radiation Oncology, Cleveland Clinic Radiation Oncology, Cleveland, Ohio; Rose Ella Burkhardt Brain Tumor and Neuro-oncology Center, Cleveland, Ohio.

View Article and Find Full Text PDF
July 2018

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.

Authors:
Lakshmi Nayak Lisa M DeAngelis Alba A Brandes David M Peereboom Evanthia Galanis Nancy U Lin Riccardo Soffietti David R Macdonald Marc Chamberlain James Perry Kurt Jaeckle Minesh Mehta Roger Stupp Alona Muzikansky Elena Pentsova Timothy Cloughesy Fabio M Iwamoto Joerg-Christian Tonn Michael A Vogelbaum Patrick Y Wen Martin J van den Bent David A Reardon

Neuro Oncol 2017 05;19(5):625-635

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

View Article and Find Full Text PDF
May 2017